Cepheid Reports Higher Revenues as Equipment Sales Increase | GenomeWeb

NEW YORK, April 23 – Cepheid of Sunnyvale, Calif., said Monday its more than tripled to $3.3 in first-quarter 2001, compared with $900,000 in the year ago period.

Cepheid attributed the increase in revenues to initial sales of its SmartCycler DNA testing system, which the company began selling through distributors in May of 2000. In January, the company began receiving revenue from sales of the SmartCycler in Europe, sold through its Belgian distributor, Eurogentec.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.